Payload‐Driven Design of Polymeric Carriers for Nucleic Acid Delivery: Insights from Structure–Function Relationships
Source abstract
Abstract
Abstract Polymeric carriers are gaining increasing attention for the delivery of a range of clinically relevant nucleic acid (NA) payloads, due to their efficacy, safety, and modular chemistry. While the requirements for an “optimal” carrier depend strongly on the NA payload, research has largely centered on carrier properties rather than the unique needs of the payload. Therefore, in this review, a novel perspective inspired by protein structural organization is introduced to explore structure–function relationships of polymeric carrier systems, highlighting the diverse requirements of different NA payloads. To gain deeper mechanistic insights, the complicated polymer/NA delivery systems are deconvoluted into four hierarchical levels, including molecular composition, structural features, complexation, and 3D integration. In addition to outlining recent experimental strategies, it is emphasized that the structural diversity and tunability of polymer chemistry provide a foundation for payload‐specific carrier design. Critical advances are expected in the molecular design of polymeric carriers to enhance NA delivery efficiency, improve biological safety and incorporate multifunctionality, particularly compared to lipid‐based platforms that are currently ahead in clinical applications. A payload‐specific design framework may guide development of next‐generation polymeric carrier systems for basic research, biotechnology, and therapeutic applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Nanopore and Nanochannel Transport Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Active Polymers Helmholtz‐Zentrum Hereon 14513 Teltow Germany
Berlin‐Brandenburg Center for Regenerative Therapies (BCRT) 13353 Berlin Germany
Pantherna Therapeutics GmbH 16761 Hennigsdorf Germany
Germany Institute of Chemistry University of Potsdam 14476 Potsdam Germany
Fraunhofer Institute for Applied Polymer Research (IAP) D‐14476 Potsdam Germany
Funding
Deutsche Forschungsgemeinschaft
References (100+)
Show source-provided references
1. 10.1038/s41573-022-00476-610.1038/s41573-022-00476-6 ↗
2. 10.1038/s41467-020-20096-110.1038/s41467-020-20096-1 ↗
3. 10.1038/s41578-024-00725-710.1038/s41578-024-00725-7 ↗
4. 10.1038/s41578-022-00529-710.1038/s41578-022-00529-7 ↗
5. 10.1016/j.jconrel.2015.09.04610.1016/j.jconrel.2015.09.046 ↗
6. 10.1016/j.jconrel.2014.04.02310.1016/j.jconrel.2014.04.023 ↗
7. 10.1128/AEM.67.1.293-299.200110.1128/AEM.67.1.293-299.2001 ↗
8. 10.1038/s41570-018-0039-110.1038/s41570-018-0039-1 ↗
9. 10.1021/ma200675w10.1021/ma200675w ↗
10. 10.1073/pnas.161002811310.1073/pnas.1610028113 ↗
11. 10.1146/annurev.biochem.78.081307.11054010.1146/annurev.biochem.78.081307.110540 ↗
12. 10.1021/mp300293n10.1021/mp300293n ↗
13. 10.1039/C7NR00532F10.1039/C7NR00532F ↗
14. 10.1038/sj.gt.330259210.1038/sj.gt.3302592 ↗
15. 10.1186/s11671-018-2728-610.1186/s11671-018-2728-6 ↗
16. 10.1038/srep3230110.1038/srep32301 ↗
17. 10.2533/chimia.1997.3410.2533/chimia.1997.34 ↗
18. 10.1039/C8TB00967H10.1039/C8TB00967H ↗
19. 10.1124/pr.58.1.810.1124/pr.58.1.8 ↗
20. 10.2147/IJN.S22241910.2147/IJN.S222419 ↗
21. Ramamoorth M. · J. Clin. Diagn. Res. · 2015 · 9 · GE01
22. 10.1073/pnas.070388210410.1073/pnas.0703882104 ↗
23. 10.1128/IAI.73.4.1907-1916.200510.1128/IAI.73.4.1907-1916.2005 ↗
24. 10.1038/cddiscovery.2016.10110.1038/cddiscovery.2016.101 ↗
25. 10.1038/sj.mt.630021710.1038/sj.mt.6300217 ↗
26. 10.1172/JCI3760710.1172/JCI37607 ↗
27. 10.4161/rna.2020610.4161/rna.20206 ↗
28. 10.1016/j.drudis.2015.07.00910.1016/j.drudis.2015.07.009 ↗
29. 10.1038/s41598-020-60506-410.1038/s41598-020-60506-4 ↗
30. 10.1016/j.cocis.2023.10172610.1016/j.cocis.2023.101726 ↗
31. 10.1038/mt.2012.7910.1038/mt.2012.79 ↗
32. 10.1038/s41578-019-0145-910.1038/s41578-019-0145-9 ↗
33. 10.1038/pj.2014.4910.1038/pj.2014.49 ↗
34. 10.1021/mp400467x10.1021/mp400467x ↗
35. 10.1080/17425247.2019.165619610.1080/17425247.2019.1656196 ↗
36. 10.1016/j.addr.2019.08.00410.1016/j.addr.2019.08.004 ↗
37. 10.1074/jbc.RA118.00430010.1074/jbc.RA118.004300 ↗
38. 10.1016/j.molcel.2019.02.01510.1016/j.molcel.2019.02.015 ↗
39. 10.1126/science.aay596710.1126/science.aay5967 ↗
40. 10.1016/j.jconrel.2016.08.00410.1016/j.jconrel.2016.08.004 ↗
41. 10.1021/acs.biomac.9b0089610.1021/acs.biomac.9b00896 ↗
42. 10.1039/D0NR03147J10.1039/D0NR03147J ↗
43. 10.1093/nar/29.4.97610.1093/nar/29.4.976 ↗
44. 10.1016/j.ymthe.2004.03.02010.1016/j.ymthe.2004.03.020 ↗
45. 10.1039/C7BM00712D10.1039/C7BM00712D ↗
46. 10.1038/nrd427810.1038/nrd4278 ↗
47. 10.1038/nature2135110.1038/nature21351 ↗
48. 10.1038/s12276-020-0407-z10.1038/s12276-020-0407-z ↗
49. 10.1073/pnas.190805211610.1073/pnas.1908052116 ↗
50. 10.1517/14712598.2015.105756310.1517/14712598.2015.1057563 ↗
51. 10.1038/s41434-020-00204-y10.1038/s41434-020-00204-y ↗
52. 10.1089/hum.2017.12110.1089/hum.2017.121 ↗
53. 10.1016/j.cell.2009.01.03510.1016/j.cell.2009.01.035 ↗
54. 10.2174/15680260677730363010.2174/156802606777303630 ↗
55. 10.1038/mtna.2015.2310.1038/mtna.2015.23 ↗
56. 10.1016/j.sbi.2007.05.00310.1016/j.sbi.2007.05.003 ↗
57. 10.1126/science.adp817910.1126/science.adp8179 ↗
58. 10.3390/biomedicines1201018710.3390/biomedicines12010187 ↗
59. 10.1002/advs.20240161710.1002/advs.202401617 ↗
60. 10.5301/ejo.500017610.5301/ejo.5000176 ↗
61. 10.1016/j.lanepe.2024.10086210.1016/j.lanepe.2024.100862 ↗
62. 10.1089/nat.2016.065710.1089/nat.2016.0657 ↗
63. 10.1007/s00005-012-0209-710.1007/s00005-012-0209-7 ↗
64. 10.1039/D4CC00018H10.1039/D4CC00018H ↗
65. McCutchan J. H. · JNCI: J. Natl. Cancer Inst. · 1968 · 41 · 351
66. 10.1016/0005-2787(75)90350-010.1016/0005-2787(75)90350-0 ↗
67. 10.1002/cbin.1115510.1002/cbin.11155 ↗
68. 10.1016/S0168-3659(02)00178-510.1016/S0168-3659(02)00178-5 ↗
69. 10.1021/bc00023a01210.1021/bc00023a012 ↗
70. 10.1295/polymj.17.11710.1295/polymj.17.117 ↗
71. 10.1021/ja00177a02710.1021/ja00177a027 ↗
72. 10.1016/j.actbio.2016.07.01510.1016/j.actbio.2016.07.015 ↗
73. 10.3390/ijms2206291210.3390/ijms22062912 ↗
74. 10.1021/acsbiomaterials.5c0033610.1021/acsbiomaterials.5c00336 ↗
75. 10.1016/j.ijpharm.2018.05.04510.1016/j.ijpharm.2018.05.045 ↗
76. 10.1073/pnas.92.16.729710.1073/pnas.92.16.7297 ↗
77. 10.1038/s41587-022-01294-210.1038/s41587-022-01294-2 ↗
78. 10.3390/pharmaceutics1202018310.3390/pharmaceutics12020183 ↗
79. 10.1039/C8PY00978C10.1039/C8PY00978C ↗
80. 10.1039/c2cs35146c10.1039/c2cs35146c ↗
81. 10.1002/macp.20110019010.1002/macp.201100190 ↗
82. 10.1016/j.ejpb.2018.10.00310.1016/j.ejpb.2018.10.003 ↗
83. 10.1021/bc060077y10.1021/bc060077y ↗
84. 10.1016/j.actbio.2017.10.02710.1016/j.actbio.2017.10.027 ↗
85. 10.1016/j.ejpb.2004.11.01110.1016/j.ejpb.2004.11.011 ↗
86. 10.1038/sj.gt.330205010.1038/sj.gt.3302050 ↗
87. 10.1002/jgm.18710.1002/jgm.187 ↗
88. 10.1021/acs.macromol.5b0194010.1021/acs.macromol.5b01940 ↗
89. 10.1038/s41467-025-59136-z10.1038/s41467-025-59136-z ↗
90. Herrero J. M. · Nat. Nanotechnol. · 2025
91. 10.1023/A:101605462354310.1023/A:1016054623543 ↗
92. 10.1016/S1369-7021(12)70165-710.1016/S1369-7021(12)70165-7 ↗
93. 10.1002/adfm.20080145710.1002/adfm.200801457 ↗
94. 10.1021/acs.macromol.5b0036010.1021/acs.macromol.5b00360 ↗
95. 10.1021/nn402072d10.1021/nn402072d ↗
96. 10.1021/acsmacrolett.1c0033510.1021/acsmacrolett.1c00335 ↗
97. 10.1021/bm201111d10.1021/bm201111d ↗
98. 10.1021/bm201693j10.1021/bm201693j ↗
99. Sun Y. · J. Appl. Polym. Sci. · 2016 · 133
100. 10.3390/molecules2420374410.3390/molecules24203744 ↗